2 Matching Annotations
  1. Last 7 days
    1. 2 F c.499C>T (Q96X) Bilateral Positive (retinal) Positive 

      PatientID: 2

      KindredID: 2

      Case: F, Age Unknown, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0000107; HP:0005584; HP:0009711; HP:0001737 (Renal cyst, Renal cell carcinoma, Retinal capillary hemangioma, Pancreatic cysts)

      CaseHPOFreeText: Bilateral RCC and renal cysts, retinal hemangioblastoma, positive for pancreatic cysts.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Table 1

      Variant: p.Q96* (c.286C>T)

      LegacyVariant: c.499C>T (Q96X)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 428804, https://www.ncbi.nlm.nih.gov/clinvar/variation/428804/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Variant is declared as “c.499C>T (Q96X)” by the authors, this was treated as a legacy variant and mapped to c.286C>T, Q96*. This study found coexpression of Epo and EpoR in 11 RCCs and in 10 benign renal cysts in a spectrum of VHL renal disease suggesting that Epo/EpoR coexpression is present in both benign and malignant stages of renal neoplasia. Six benign cysts stained for Epo but not EpoR. The researchers detected loss of heterozygosity of a wild-type VHL allele in different RCCs with microsatellite markers, D3S1110 and D3S2452, flanking the VHL gene

      MutationType: stop_gained; missense_variant;transition

      CivicName: Q96* (c.286C>T)

      MultipleGeneVariants: N/A

    1. GroupID: 48

      DiseaseAssertion: VHL

      GroupSize: N/A

      GroupNumberMales: N/A

      GroupNumberFemales: N/A

      GroupEthnicity: N/A

      GroupAgeRange: N/A

      GroupInfo: VHL family found to have a germline rearrangement of the VHL gene. The number of family members included in this study is not specified.

      GroupPresentingHPOs: N/A

      GroupHPOFreeText: Patients within this family were found to have a clinical diagnosis of VHL disease, however, the presenting phenotypes were not specified.

      GroupNotHPOs: HP:0002666 (Pheochromocytoma)

      GroupNotHPOFreeText: N/A

      GroupPreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.Q96* (c.286C>T)

      LegacyVariant: c.499C>T

      CaseProblemVariantFreeText: N/A

      ClinVarID: 428804, https://www.ncbi.nlm.nih.gov/clinvar/variation/428804/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: Q96* (c.286C>T)

      MultipleGeneVariants: N/A